We are live on !
Find out more
Aptevo Therapeutics
APVO
APVO
hedge funds and large institutions have $2.64M invested in Aptevo Therapeutics in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
1.16% more ownership
Funds ownership: 15.88% → 17.04% (+1.2%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $340K
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$283K |
| 2 |
Veritable
Wilmington,
Delaware
|
-$56K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$555 |